TALPHERA, INC. Restricted Stock or Unit Expense
TALPHERA, INC. (TLPH) reported Restricted Stock or Unit Expense of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2017-03-03
- TALPHERA, INC. restricted stock or unit expense for fiscal 2016 was $0.00.
- TALPHERA, INC. restricted stock or unit expense for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- TALPHERA, INC. restricted stock or unit expense for fiscal 2014 was $56.00K, a 80.69% decline from fiscal 2013.
- TALPHERA, INC. restricted stock or unit expense for fiscal 2013 was $290.00K, a 7.94% decline from fiscal 2012.
| Period end | Restricted Stock or Unit Expense 12 month | Restricted Stock or Unit Expense 90 month |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-03 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-03 | |
| 2014-12-31 | $56.00K 10-K · filed 2017-03-03 | |
| 2013-12-31 | $290.00K 10-K · filed 2016-03-07 | |
| 2012-12-31 | $315.00K 10-K · filed 2015-03-13 | $807.00K 10-K · filed 2013-03-12 |
| 2011-12-31 | $492.00K 10-K · filed 2014-03-17 | |
| 2010-12-31 | $0.00 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |